Indivior Reaches $86M Opioid Settlement With 16 U.S. States July 29, 2024 By Jonathan Stempel Indivior reached an $86 million settlement with 16 U.S. states over the drug manufacturer’salleged role in spreading opioid addiction across...
Drugmaker Indivior Agrees to Pay $30M to Settle Suboxone Monopoly Claims August 22, 2023 By Brendan Pierson Indivior has agreed to pay $30 million to settle a class action lawsuit filed in a U.S. court by health...
Former Indivior CEO Pleads Guilty in U.S. in Opioid Addiction Treatment Probe July 2, 2020 By Nate Raymond Shaun Thaxter, the former chief executive of drugmaker Indivior Plc, pleaded guilty on Tuesday to a criminal charge arising out...
Teva Wins Patent Case Related to Orexo Opioid-Treatment Drug April 1, 2019 By Christopher Yasiejko A U.S. jury on Friday rejected a claim by Sweden’s Orexo AB that two generic opioid-addiction treatments created by Teva...